ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 200692 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 200692; 2) Community: the network communities that were significantly associated with the response to NSC 200692; 3) Molecule: the relationships between components within communities and NSC 200692; 4) MDR: the compounds that were significantly associated with the NSC 200692.

NSC Compound Enrichment Correlation
NSC 18298 Null 0.0178844438004191 0.19077206
NSC 302991 Camptothecin Derivative 0.0178844438004191 -0.12412741
NSC 734148 2-(4-Chloro-benzenesulfonylimino)-imidazolidine-1-carbodithi oic acid 3-thioxo-5,6-dihydro-imidazo[2,1-c][1,2,4] thiadiazol-7-yl ester 0.0178844438004191 -0.17706655
NSC 321206 Null 0.0178844438004194 -0.32187995
NSC 350895 Bleomycin A5 0.0178844438004194 0.34946773
NSC 624172 Null 0.0178844438004194 -0.2843264
NSC 625496 Null 0.0178844438004194 -0.25490681
NSC 627744 Null 0.0178844438004194 -0.42500655
NSC 628916 3-(3,N,N-diethylaminopropylamino)-1,2,4-benzotriazine 1,4-dioxide. 0.33 Hydrate 0.0178844438004194 -0.22271162
NSC 634035 4-amino-3-iodo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazin-7-one 0.0178844438004194 -0.23155842
Total:83  Current:38    [First] [Prev] [Next] [Last]